News Daily News Access to GLP-1 Drugs Unequal for US Patients With Obesity Caitlin E. Cox May 01, 2025
News Daily News Lorundrostat Lowers BP in Treatment-Resistant Hypertension: Advance-HTN Yael L. Maxwell April 29, 2025
News Conference News AHA 2024 Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III Caitlin E. Cox November 21, 2024
News Features GDMT Uptake Remains Dismal in HFrEF: What’s the Right Fix? Todd Neale November 13, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Daily News Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows L.A. McKeown October 09, 2024
News Daily News Balancing Hypertension and Fall Risk: A Delicate Dance in Elderly Patients L.A. McKeown April 22, 2024
News Daily News Patients With CKD Remain Underrepresented in Trials of CV Meds Todd Neale March 08, 2024
News Daily News GLP-1 Receptor Agonists Come With Broad Array of Benefits, Risks Todd Neale January 21, 2024
News Daily News Diabetes in Middle Age Linked to Earlier CVD Risk: Danish Study L.A. McKeown October 10, 2023
News Daily News European Regulators Investigating CV Safety of Weight-Loss Drug Mysimba Michael O'Riordan September 15, 2023
News Conference News ACC 2023 No Downside to Immediate Complete Revascularization in ACS: BIOVASC Michael O'Riordan March 06, 2023
Presentation ACC 2023 Complete Revascularization Strategies in Patients Presenting With Acute Coronary Syndrome and Multivessel Coronary Disease Presenter: Roberto Diletti March 05, 2023
News Conference News AHA 2022 High-Sensitivity Troponin Testing on the Rise in the US but Still Limited Michael O'Riordan November 04, 2022